- Investing Ideas
- /
- Global Healthcare Undervalued over 20% based on DCF
Global Healthcare Undervalued over 20% based on DCF
UPDATED Dec 04, 2023
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
200 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MATD3Hospital Mater Dei | R$7.84 | 7.3% | 6.5% | R$3.0b | R$10.91 | PE27.8x | E32.5% | 0.8% | ||
| AKTAkdital | د.م489.90 | 1.0% | n/a | د.م6.2b | د.م448.50 | PE48.1x | E42.1% | 0.7% | ||
| A287410Jeisys Medical | â‚©10,550.00 | -7.1% | 28.8% | â‚©799.9b | â‚©15,212.50 | PE29.9x | E26.9% | n/a | ||
| 1501Shanghai Kindly Medical Instruments | HK$27.80 | -1.2% | -1.2% | HK$4.8b | HK$33.33 | PE26.9x | E28.2% | 0.9% | ||
| 6929OrbusNeich Medical Group Holdings | HK$5.71 | -28.6% | n/a | HK$4.7b | HK$9.91 | PE17x | E13.3% | n/a | ||
| SIASienna Senior Living | CA$10.94 | -0.09% | -2.8% | CA$796.1m | CA$13.17 | PS1x | S1.3% | 8.6% | ||
| 6922Cryofocus Medtech (Shanghai) | HK$18.96 | 0.1% | n/a | HK$4.5b | HK$27.95 | PS115.8x | E50.6% | n/a | ||
| REGRegis Healthcare | AU$2.91 | 5.8% | 45.5% | AU$876.0m | AU$3.11 | PS1.1x | E82.1% | 3.3% | ||
| AMSAdvanced Medical Solutions Group | UK£2.01 | -5.6% | -26.0% | UK£436.8m | UK£2.52 | PE22.2x | E6.7% | 1.1% | ||
| 3309C-MER Eye Care Holdings | HK$3.41 | -8.1% | -31.3% | HK$4.3b | HK$4.50 | PS2.4x | E113.2% | 0% | ||
| MIDANAl-Maidan Clinic for Oral Health Services Company K.S.C.P | د.ك0.80 | 0% | 14.6% | د.ك161.0m | n/a | PE10.8x | n/a | 0.6% | ||
| SBSStratec | €38.60 | -6.1% | -54.0% | €469.2m | €54.00 | PE39x | E27.2% | 2.5% | ||
| SRDXSurmodics | US$33.64 | -0.3% | -5.5% | US$472.7m | US$58.50 | PS3.6x | E-21.4% | n/a | ||
| 9729TOKAI | JPÂ¥1,902.00 | -0.7% | 1.7% | JPÂ¥66.9b | JPÂ¥2,145.00 | PE11.9x | E1.0% | 3.4% | ||
| ARVArvida Group | NZ$0.98 | -7.5% | -21.6% | NZ$713.4m | NZ$1.44 | PE8.6x | E2.5% | 2.4% | ||
| EXEExtendicare | CA$7.05 | 1.3% | 4.4% | CA$591.2m | CA$7.08 | PE33.3x | S2.3% | 6.8% | ||
| GHCGarofalo Health Care | €4.50 | -1.1% | 17.3% | €398.6m | €6.00 | PE17.3x | E7.8% | n/a | ||
| MASTERMaster Style | ฿56.00 | 6.2% | n/a | ฿14.8b | ฿78.11 | PE44.6x | E37.5% | 0.04% | ||
| 2219Chaoju Eye Care Holdings | HK$4.58 | 0.2% | 19.3% | HK$3.1b | HK$7.37 | PE12.2x | E18.8% | 3.7% | ||
| CEVICellaVision | kr169.00 | -4.0% | -19.5% | kr4.1b | kr191.75 | PE35.9x | E24.6% | 1.3% | ||
| A335890VIOL | â‚©8,470.00 | 5.6% | 202.0% | â‚©488.4b | â‚©9,500.00 | PE34.2x | E32.9% | 0.1% | ||
| ACLAustralian Clinical Labs | AU$2.64 | 4.3% | -18.3% | AU$529.3m | AU$3.56 | PE14.7x | E8.6% | 5.3% | ||
| MVFMonash IVF Group | AU$1.31 | 2.3% | 33.7% | AU$510.4m | AU$1.42 | PE23.4x | E14.1% | 3.4% | ||
| PRDAProdia Widyahusada | Rp5,400.00 | -3.6% | -10.0% | Rp5.1t | Rp6,926.00 | PE15.2x | E16.8% | 4.4% |